Alendronate Sodium 121268-17-5
Alendronic acid (INN) or alendronate sodium (USAN, sold as Fosamax by Merck) is a bisphosphonate drug used for osteoporosis and several other bone diseases. It is marketed alone as well as in combination with vitamin D (2,800 U and 5600 U, under the name Fosamax+D). Merck's U.S. patent on alendronate expired in 2008 and Merck lost a series of appeals to block a generic version of the drug from being certified by the U.S. Food and Drug Administration (FDA).
read more [+]| Systematic (IUPAC) name: | sodium[4-amino-1-hydroxy-1-(hydroxy-oxido-phosphoryl)-butyl]phosphonicacidtrihydrate |
|---|---|
| Alendronate Sodium CAS number: | 121268-17-5 |
| ATC code: | M05BA04 |
| PubChem: | 2088 |
| DrugBank: | APRD00561 |
| Formula: | C4H18NNaO10P2 |
| Molecular mass: | 325.124 g/mol |
| Alendronate Sodium Assay/Purity: | Typically NLT 98% |
